-

Exactech AI Platform Surpasses 100,000 Joint Replacement Surgeries Worldwide

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced today its Active Intelligence® (AI) platform surpassed more than 100,000 total joint replacement surgeries across the globe.

“We are proud to reach this incredible milestone of more than 100,000 patients with the support of our surgeon partners worldwide,” said Exactech CEO Darin Johnson. “As a leader in orthopaedic innovations, Exactech is focused on pushing technological boundaries to deliver a best-in-class platform of enabling technologies and smart solutions. With a commitment to research and transformative technologies, such as a first-to-market surgical guidance system, machine learning-based tools and personalized planning solutions, we are delivering on our vision to unlock data insights through cross-platform, economical innovations that improve clinical outcomes.”

Active Intelligence was launched in 2021 as a dynamic ecosystem of enabling technologies and smart solutions that provides unparalleled support to surgeons in and out of the operating room. With powerful planning software, prediction tools, disruptive surgical technologies and engagement opportunities, Exactech AI empowers surgeons with data-rich, low-cost solutions that help improve patient outcomes.

Some notable achievements of Exactech AI include:

  • Informed by the collective intelligence of thousands of surgeries, powerful tools have enabled more than 2,500 personalized patient predictions by more than 450 surgeons around the world.
  • Expanded globally this year, personalized preoperative planning software allows surgeons to plan shoulder component placement and select implants and sizes for the scapula and humerus based on each patient’s specific anatomy.
  • With no capital cost, more than 500 GPS stations are used by thousands of surgeons in hospitals and ASC centers around the world, and in nearly half of Exactech shoulder cases.
  • Modern alignment philosophies are supported through our ligament-driven Newton Knee platform, which is now used in more than half of our guided, personalized knee surgery cases.
  • A first-of-its-kind clinical exchange app connects all Exactech surgeons worldwide.

For more information, visit www.ExactechAI.com.

ExactechGPS, Equinoxe Planning App and Predict+ are developed by Blue Ortho, an Exactech subsidiary, and distributed by Exactech, Inc.

About Exactech

Exactech is a global medical device company that develops and markets orthopaedic implant devices, related surgical instruments and the Active Intelligence® platform of smart technologies to hospitals and physicians. Headquartered in Gainesville, Fla., Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Visit www.exac.com for more information and connect with us on LinkedIn, Vumedi, YouTube, Instagram and Twitter. With Exactech by your side, you’ve got EXACTLY what you need.

Contacts

Courtney Adkins
Marketing Communications Director
media@exac.com

EXACTECH INC.

Details
Headquarters: Gainesville, Fla.
Website: www.exac.com
CEO: Darin Johnson
Employees: 800
Organization: PRI

Release Versions

Contacts

Courtney Adkins
Marketing Communications Director
media@exac.com

More News From EXACTECH INC.

Exactech Announces FDA 510(k) Clearance of the World’s First Surgical Navigation for Total Ankle Replacement

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced its subsidiary, BlueOrtho, has received 510(k) clearance from the Food and Drug Administration for ExactechGPS® Ankle, the world’s first surgical navigation system for total ankle arthroplasty (TAA). GPS Ankle is a first-of-its-kind technology, which connects the preoperative plan with real-time intraoperative instrument g...

Exactech Publishes New Machine Learning Research That Evaluates Fairness and Accuracy of AI Predictions

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, reports a new study1 that demonstrates its machine learning clinical decision support tool, Predict+™, creates fair and accurate outcomes predictions for shoulder arthroplasty patients of different ethnicity, sex and age. The study, the first of its kind in orthopaedics, has just been published in the Journal of Shoulder and Elbow...

Newton Surgeon Using Groundbreaking Technology for Guided Personalized Shoulder Replacement Surgeries

BOSTON--(BUSINESS WIRE)--Orthopaedic surgeon Dr. Daniel Quinn is now using computer-assisted technology to offer guided personalized surgery for shoulder replacements in the area. ExactechGPS® Guided Personalized Surgery is the latest advancement in technology that provides surgeons with real-time visual guidance and alignment data in total shoulder surgery. Similar to a navigation device in your car, this platform provides a visual map of the patient’s joint on a screen, allowing surgeons to c...
Back to Newsroom